ESR1 and breast carcinoma: Nevertheless, IHC analyses on a breast cancer tissue microarray allowed us to detect cytoplasmic ERα protein primarily in those specimens lacking nuclear ERα expression, by using an ERα C-terminal antibody (36.8% of samples).